Table 3.
Women (n=1208) | ||
Marginal RD | 95% CI | |
2001 | 0.04 | (−0.02, 0.10) |
2003 | 0.13 | (0.04, 0.21)a |
2012 | 0.07 | (−0.02, 0.15) |
Men (n=1225) | ||
Marginal RD | 95% CI | |
2001 | 0.00 | (−0.05, 0.06) |
2003 | −0.02 | (−0.11, 0.07) |
2012 | 0.08 | (0.00, 0.16)b |
Source: Mexican Health and Aging Study, 2001 – 2012. Note: Analyses restricted to respondents who reported > 1 ADL/IADL in a given wave
Notes:
e-value, or minimum strength of association that an unmeasured confounder would have to have between treatment and outcome (on the risk ratio scale) necessary to reduce observed risk differences to the null (assuming that those associations are of identical size) = 1.68 (lower bound of 95% CI: 1.33)
e-value: 1.56 (lower bound: 1.42).